Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 19, 2019
Early infectious complications after autologous hematopoietic cell transplantation for multiple myelomaShafia Rahman, Lisa Rybicki, Betty Ky Hamilton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantationNavin Wadehra, Sherif Farag, Brian Bolwell, et al.
Leukemia & Lymphoma|February 15, 2011
Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphomaBrian T Hill, Lisa Rybicki, Stephen Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 2, 2011
Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT)Nelli Bejanyan, Brian J Bolwell, Aleksandr Lazaryan, et al.
British Journal of Haematology|January 13, 2011
The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controlsBrian T Hill, Lisa Rybicki, Brian J Bolwell, et al.
Clinical Lymphoma|September 30, 2004
Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphomaLeo I Gordon, Thomas Witzig, Arturo Molina, et al.
Hematology/Oncology and Stem Cell Therapy|July 18, 2015
Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancerBetty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Journal of Clinical Apheresis|June 8, 2011
Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yieldHien K Duong, Brian J Bolwell, Lisa Rybicki, et al.
Research and Practice in Thrombosis and Haemostasis|April 24, 2019
Implementation of an electronic medical record tool for early detection of deep vein thrombosis in the ambulatory oncology settingGirish Kunapareddy, Benjamin Switzer, Prantesh Jain, et al.
Seminars in Hematology|January 29, 2021
A pilot clinical trial of oral tetrahydrouridine/decitabine for noncytotoxic epigenetic therapy of chemoresistant lymphoid malignanciesBrian Hill, Deepa Jagadeesh, Brad Pohlman, et al.
Pageof 8